Takeda Pharmaceutical Company Limited
Heterocyclic compound

Last updated:

Abstract:

Provided is a heterocyclic compound having a superior RBP4-lowering action and useful as a medicament for the prophylaxis or treatment of a disease or symptom mediated by an increase in RBP4 or retinol supplied by RBP4. A compound represented by the formula (I): ##STR00001## wherein each symbol is as defined in the Description, or a salt thereof has a superior RBP4-lowering action, and is useful as a medicament for the prophylaxis or treatment of a disease or symptom mediated by an increase in RBP4 or retinol supplied by RBP4.

Status:
Grant
Type:

Utility

Filling date:

27 Jan 2020

Issue date:

13 Apr 2021